Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Preliminary efficacy and safety of TT-01488, a novel, non-covalent, reversible BTK inhibitor, in patients with relapsed/refractory mantle cell lymphoma

Blood (2025) 146 (Supplement 1): 1824.

https://doi.org/10.1182/blood-2025-1824

Published: 2025

Journal Articles

R-cmop and pola-R-CMP regimens as first-line treatment for diffuse large B-cell lymphoma with cardiac comorbidity: A prospective, single-arm, multicenter study

Jinhua Liang, Yue Li, Haorui Shen, Jiazhu Wu, Hua Yin, Li Wang, Maozhong Xu, Xu Wei

Blood (2025) 146 (Supplement 1): 1920.

https://doi.org/10.1182/blood-2025-1920

Published: 2025

Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Blood (2025) 146 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2025-6293

Published: 2025

Journal Articles

Molecular insights from ctdna dynamics: Monitoring MRD and tracking divergent progression modes and clonal evolution patterns

Jinhua Liang, Yi-Fan Wu, Yi-Lun Ji, Liu-Qing Zhu, Li Wang, Jianyong Li, Xu Wei

Blood (2025) 146 (Supplement 1): 1889.

https://doi.org/10.1182/blood-2025-1889

Published: 2025

Journal Articles

A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined with Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/Penpulimab (Pola-RCHP-X) Versus RCHOP-X and Pola-Rchp in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma

Jinhua Liang, Li Wang, Haorui Shen, Hua Yin, Jiazhu Wu, Yue Li, Bihui Pan, Xinyu Zhang, Yilin Kong, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1742.3.

https://doi.org/10.1182/blood-2024-207064

Published: 2024

Journal Articles

Multi-Omics Profiling Reveals Tumor Cellular Landscape and Metabolism Remodeling during Extranodal Natural Killer/T-Cell Lymphoma (ENKTL) Metastasis and Progression

Jinhua Liang, Kai-Xin Du, Yue Li, Tong-Yao Xing, Hao-Rui Shen, Jiazhu Wu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 2961.

https://doi.org/10.1182/blood-2024-201455

Published: 2024

Journal Articles

R-Cmop and Pola-R-CMP Regimes As First-Line Treatment for Diffuse Large B-Cell Lymphoma with Cardiac Comorbidity

Jinhua Liang, Yue Li, Haorui Shen, Jiazhu Wu, Hua Yin, Li Wang, Xu Wei

Blood (2024) 144 (Supplement 1): 6532.

https://doi.org/10.1182/blood-2024-212300

Published: 2024

Journal Articles

Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort

Jinhua Liang, Yi-fan Wu, Jun-heng Liang, Yue Li, Xin-Yu Zhang, Hao-Rui Shen, Jiazhu Wu, Liu qing Zhu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 576.

https://doi.org/10.1182/blood-2024-194820

Published: 2024

Journal Articles

A Phase 2 Multicenter Study of Pegaspargase in Combination with Gemcitabine, Etoposide, Mitoxantrone Hydrochloride Liposome, and Dexamethasone (P-GEMD) for Newly Diagnosed Early Non-Upper Aero-Digestive Tract or Advanced Stage Extranodal NK/T Cell Lymphoma

Jinhua Liang, Hao-Rui Shen, Hua Yin, Jiazhu Wu, Yue Li, Li Wang, Jianyong Li, Liang Wang, Xu Wei

Blood (2024) 144 (Supplement 1): 6396.

https://doi.org/10.1182/blood-2024-203071

Published: 2024

Journal Articles

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Jiazhu Wu, Jun-heng Liang, Liu-Qing Zhu, Hua Yin, Yue Li, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1709.

https://doi.org/10.1182/blood-2024-201220

Published: 2024

Journal Articles

The First-in-Class PTPN2/1 Inhibitor Abbv-CLS-484 Disrupts Mitochondrial Renewal and Blocks Tfrc-Mediated PINK1-Prkn-Dependent Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma

Jinhua Liang, Weiting Wang, Ziwen Duan, Tong-Yao Xing, Hao-Rui Shen, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 2742.

https://doi.org/10.1182/blood-2024-201488

Published: 2024

Journal Articles

Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma：a Phase 2 Multicenter Study

Jinhua Liang, Hao-Rui Shen, Hua Yin, Jiazhu Wu, Yue Li, Li Wang, Lintao Bi, Weiwei Qin, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1725.

https://doi.org/10.1182/blood-2024-202967

Published: 2024

Journal Articles

Efficacy and Safety of Avatrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia Refractory to Rhtpo in Patients with Lymphoma

Xu Wei, Hao-Rui Shen, Xin-Yu Zhang, Jiazhu Wu, Hua Yin, Yue Li, Jinhua Liang, Li Wang

Blood (2023) 142 (Supplement 1): 5452.

https://doi.org/10.1182/blood-2023-184420

Published: 2023

Journal Articles

A Retrospective Study on the Efficacy and Safety of Chidamide As a Maintenance Therapy for Peripheral T-Cell Lymphoma

Hao-Rui Shen, Jinhua Liang, Jiazhu Wu, Hua Yin, Li Wang, Yue Li, Jianyong Li, Xu Wei

Blood (2023) 142 (Supplement 1): 6208.

https://doi.org/10.1182/blood-2023-181486

Published: 2023

Journal Articles

Clinical Implications of CSF-Ctdna in CNS Involvement of Newly Diagnosed Diffuse Large B Cell Lymphoma: An Improvement of Diagnosis, Treatment and Evaluation

Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Yue Li, Jun-heng Liang, Xin-Yu Zhang, Sibusiso Luthuli, Jiazhu Wu, Liu qing Zhu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2023) 142 (Supplement 1): 188.

https://doi.org/10.1182/blood-2023-181666

Published: 2023

Journal Articles

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Blood (2023) 142 (Supplement 1): 1900.

https://doi.org/10.1182/blood-2023-183071

Published: 2023

Journal Articles

PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r ENKTL): Updates of the Phase Ib/II Scent Study

Gao Yan, Liling Zhang, Wenyu Li, Xu Wei, Ru Feng, Xue-Ping Li, Yu Chen, Huijing Wu, Xiaoxiao Wang, Bing Bai, Huiqiang Huang

Blood (2023) 142 (Supplement 1): 1689.

https://doi.org/10.1182/blood-2023-186252

Published: 2023

Journal Articles

Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients

Jiazhu Wu, B. S., Xiaojing Xu, PhD, Lirong Pei, B.S., Eun-Joon Lee, PhD, Austin Shull, B.S., Farrukh Awan, MD MS, Xiaoling Wang, PhD, Lei Fan, MD, PhD, Li Jianyong, MD PhD, Xu Wei, MD PhD, Huidong Shi, PhD

Blood (2014) 124 (21): 3552.

https://doi.org/10.1182/blood.V124.21.3552.3552

Published: 2014

Journal Articles

Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation

Hong Ming, Sixuan Qian, Liu Peng, Wu Hanxin, Qiu Hongxia, Lu Hua, Zhang Sujiang, Xu Wei

Blood (2012) 120 (21): 4539.

https://doi.org/10.1182/blood.V120.21.4539.4539

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Preliminary efficacy and safety of TT-01488, a novel, non-covalent, reversible BTK inhibitor, in patients with relapsed/refractory mantle cell lymphoma

R-cmop and pola-R-CMP regimens as first-line treatment for diffuse large B-cell lymphoma with cardiac comorbidity: A prospective, single-arm, multicenter study

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Molecular insights from ctdna dynamics: Monitoring MRD and tracking divergent progression modes and clonal evolution patterns

Multi-Omics Profiling Reveals Tumor Cellular Landscape and Metabolism Remodeling during Extranodal Natural Killer/T-Cell Lymphoma (ENKTL) Metastasis and Progression

R-Cmop and Pola-R-CMP Regimes As First-Line Treatment for Diffuse Large B-Cell Lymphoma with Cardiac Comorbidity

Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort

A Phase 2 Multicenter Study of Pegaspargase in Combination with Gemcitabine, Etoposide, Mitoxantrone Hydrochloride Liposome, and Dexamethasone (P-GEMD) for Newly Diagnosed Early Non-Upper Aero-Digestive Tract or Advanced Stage Extranodal NK/T Cell Lymphoma

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

The First-in-Class PTPN2/1 Inhibitor Abbv-CLS-484 Disrupts Mitochondrial Renewal and Blocks Tfrc-Mediated PINK1-Prkn-Dependent Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma

Novel Targeted Agents in Combination with R-MINE (RMINE+X) Based on Different Molecular Subtypes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma：a Phase 2 Multicenter Study

Efficacy and Safety of Avatrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia Refractory to Rhtpo in Patients with Lymphoma

A Retrospective Study on the Efficacy and Safety of Chidamide As a Maintenance Therapy for Peripheral T-Cell Lymphoma

Clinical Implications of CSF-Ctdna in CNS Involvement of Newly Diagnosed Diffuse Large B Cell Lymphoma: An Improvement of Diagnosis, Treatment and Evaluation

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r ENKTL): Updates of the Phase Ib/II Scent Study

Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients

Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only